Tumor regressive effect of grape juice [Enoant] on ehrlich ascites carcinoma of mice

• Autorzy: Taskin E I , Yagci A. , Firat U.B. , Caner M. , Dogruman H.
• Języki publikacji: EN

Abstrakty

EN

Enoant® is a nutritional reinforcement produced from the grape’s stem, peel and seeds. In recent years grape products such as wine and grape juice have acquired a great importance because of their polyphenol components, which have a strong antioxidant effect. Those antioxidant effects of polyphenols have an ability to inhibit proliferation and induce apoptosis in cancer depending on the types of cancer and application doses. In our study we have aimed to investigate the tumor regressive effects of Enoant® in solid EAC tumor model in Balb-c mice. Animals were randomly divided into 2 groups in this study. 0.5 ml of Enoant® was administered daily to ENTgroup and the same volume of NaCl 0.9% was administered to the control group. Animals continued to receive those applications till sacrification day. On the 8th day 2 × 10⁶ EAC cells in 0.5 ml NaCl 0.9% were injected subcutaneously into the mice’s napes. On day 22 all animals were sacrificed under ether anesthesia. Using PCNA immunohistochemical staining, TUNEL technique, we observed the proliferative and apoptotic cell density changes in tumor tissues as well as the effect of Enoant® on these two phenomena. Dietary Enoant® significantly regressed tumor development in mice. It has been observed that the administration of Enoant® displayed positive effects on EAC tumor’s weight and size when compared with control group animals. Mean tumor weights’ meaningfulness was p < 0.01 and mean short-long diameters’ meaningfulness were p < 0.05 and p<0.01, respectively. It has been determined that while the PCNA index was low (p < 0.05) in the Enoant® administered group, the apoptotic index that has been established with TUNEL technique was high (p < 0.01). As a result, Enoant® has a regressive function on EAC tumor cells. By inducing apoptosis, ENT inhibited the development of tumors. It is thought that ability of ENT was welded from its strong antioxidant polyphenol component. Because of that the use of Enoant® as a dietary supplement is thought to be a factor for inhibiting cancer development.

Słowa kluczowe

EN

mice; mouse; black grape; fruit; grape juice; Enoant preparation; antioxidative property; anticancer property; apoptosis; carcinoma; ehrlich ascites carcinoma; proliferating cell nuclear antigen; PCNA zob.proliferating cell nuclear antigen

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 08
• Opis fizyczny: p.926-930,fig.,ref.

Twórcy

autor

Taskin E I

• Istanbul University, Avcilar, 34320 Istanbul, Turkey

autor

Yagci A.

autor

Firat U.B.

autor

Caner M.

autor

Dogruman H.

Bibliografia

• 1.Bagchi D., Garg A., Krohn R., Bagchi M., Bagchi D. J., Balmoori J., Stohs S. J.: Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen. Pharmacol. 1998, 30, 771-776.
• 2.Bagchi D., Garg A., Krohn R. L., Bagchi M., Tran M. X., Stohs S. J.: Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Commun. Mol. Pathol. Pharmacol. 1997, 95, 179-189.
• 3.Bedi A., Pastricha P. J., Akhtar A. J., Barber J., Bedi G. C., Giardiello F. M., Zehnbauer B. A., Hamilton S. R., Jones R. J.: Inhibition of apoptosis during the development of colorectal cancer. Cancer Res. 1995, 55, 1811-1816.
• 4.Birt D. F., Hendrich S., Wang W.: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology, Therapeutics 2001, 90, 157-177.
• 5.Block G., Patterson B., Subar A.: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 1992, 18, 1-29.
• 6.Bombardelli E., Morazzoni P.: Vitis vinifera L. Fitoterapia 1995, 66, 291-317.
• 7.Bravo L.: Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333.
• 8.Dhanalakshmi S., Agarwal R., Agarwal C.: Inhibition of NF-kappaB pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells. Int. J. Oncol. 2003, 23, 721-727.
• 9.ElAttar T. M., Virji A. S.: Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999, 10, 187-193.
• 10.Ferrari C. K., Torres E. A.: Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed. Pharmacother. 2003, 57, 251-260.
• 11.Gao X., Xu Y. X., Divine G., Janakiraman N., Chapman R. A., Gautam S. C.: Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound foun in grapes. J. Nutr. 2002, 132, 2076-2081.
• 12.Gardner S. H., Hawcroft G., Hull M. A.: Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells. Br. J. Cancer 2004, 91, 153-163.
• 13.Guisado E. P., Barrientos A. A., Navarro S. M., Josefat B. S., Salguero P. M. F.: The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochemical Pharmacology. 2002, 64, 1375-1386.
• 14.Hsieh T. C., Halicka D., Lu X., Kunicki J., Guo J., Darzynkiewicz Z., Wu J. M.: Effects of resveratrol on G0-G1 transition and cell cycle progression of mitogenically stimulated human lymphocytes. Biochem. Biophys. Res. Comm. 2002, 297, 1311-1317.
• 15.Kandaswami C., Perkins E., Soloniuk D. S., Drzewiecki G., Middleton E. Jr.: Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett. 1991, 56, 147-152.
• 16.Kondo K., Uchida R., Tokutake S., Maitani T.: Polymeric grape-seed procyanidins, but not monomeric catectins and oligomeric procyanidins, impair degranulation and membrane ruffling in RBL-2H3 cells. Bioorg. Med. Chem. 2006, 14, 641-649.
• 17.Kuo S. M.: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996, 110, 41-48.
• 18.Liao S., Umetika Y., Guo J., Kokontis M. J., Hiipakka A. R.: Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995, 96, 239-243.
• 19.Mackenzie G. G., Carrasquedo F., Delfino J. M., Keen C. L., Fraga C. G., Oteiza P. I.: Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappa B activation at multiple steps in Jurkat T cells. FASEB J. 2004, 18, 167-169.
• 20.Messina M., Descheemaker K., Erdman J. W. Jr.: The role of soy in preventing and treating chronic disease. Am. J. Clin. Nutr. 1998, 68, 1329S.
• 21.Morre D. M., Morre D. J.: Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions. Cancer Lett. 2006, 238, 202-209.
• 22.Murray M., Pizzorno J.: Procyanidolic oligomers, [in:] Murray M., Pizzorno J. (eds.): The Textbook of Natural Medicine. Churchill Livingston London 1999, 899-902.
• 23.Nomoto H., Iigo M., Hamada H., Kojima S., Tsuda H.: Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr. Cancer 2004, 49, 81-88.
• 24.Ohno H.: Effects of Testosterone on Cell Proliferation and Apoptosis in BBN Induced Mouse Urinary Bladder Carcinogenesis. Yonago Acta Medica 2000, 43, 121-130.
• 25.Piantelli M., Rinelli A., Macri E., Maggiano N., Larocca L. M., Scerrati M., Roselli R., Iacoangeli M.: Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 1993, 71, 193-198.
• 26.Reinacher-Schick A., Schoeneck A., Graeven U., Schwarte-Waldhoff I., Schmiegel W.: Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis 2003, 24, 443-451.
• 27.Romeyer F., Macheix J., Sapis J.: Changes and importance of oligomeric procyanidins during maturation of grape seeds. Phytochemistry 1986, 25, 219-221.
• 28.Seno H., Oshima M., Ishikawa T. O., Oshima H., Takaku K., Chiba T., Narumiya S., Taketo M. M.: Cyclooxygenase-2 and prostaglandin E(2)receptor EP(2)-dependent angiogenesis in APC (Delta 716) mouse intestinal polyps. Cancer Res. 2002, 62, 506-511.
• 29.Shimizu M., Weinstein B.: Modulation of signal transduction by tea catechins and related phytochemicals. Mutation Res. 2005, 591, 147-160.
• 30.Singh R. P., Tyagi A. K., Dhanalakshmi S., Agarwal C.: Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and insulin-like growth factor binding protein-3. Int. J. Cancer 2004, 108, 733-740.
• 31.So F. V., Guthrie N., Chambers A. F., Moussa M., Carroll K. K.: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer 1996, 26, 167-181.
• 32.Soleas G. J., Grass L., Josephy P. D., Goldberg D. M., Diamandis E. P.: A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin. Biochem. 2002, 35, 119-124.
• 33.Steinmetz K. A., Potter J. D.: Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991, 2, 325-357.
• 34.Sun B. C., Zhao X. L., Zhang S. W., Liu Y. X., Wang L., Wang X.: Sulindac induces apoptosis and protects against colon carcinoma in mice. World J. Gastroenterol. 2005, 18, 2822-2826.
• 35.Waladkhani A. R., Clemens M. R.: Effect of dietary phytochemicals on cancer development. Int. J. Mol. Med. 1998, 1, 747-753.
• 36.Wattenberg L. W.: Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 1992, 52 (suppl.), 2085-2091.